Wells Fargo & Company »

Eyepoint Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $209k 9.0k 23.11
2023-09-30 $66k 8.3k 7.99
2023-06-30 $113k 13k 8.70
2022-09-30 $2.0k 236 8.47
2022-06-30 $4.0k 509 7.86
2022-03-31 $105k 8.7k 12.14
2021-12-31 $195k 16k 12.26
2021-09-30 $615k 59k 10.43
2021-06-30 $23k 2.6k 9.05
2021-03-31 $25k 2.4k 10.34
2020-12-31 $0 2.4k 0.00